Myopericardial Diseases : (Record no. 106927)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 06882nam a22004573i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC4415551 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729130324.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2016 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783319271569 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9783319271545 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC4415551 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL4415551 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr11161393 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaONFJC)MIL898892 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)940506567 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC666-701.2 |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.12 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Imazio, Massimo. |
| 245 10 - TITLE STATEMENT | |
| Title | Myopericardial Diseases : |
| Remainder of title | Diagnosis and Management. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Cham : |
| Name of producer, publisher, distributor, manufacturer | Springer International Publishing AG, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2016. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2016. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (169 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- Preface -- Contents -- Part I: General Evaluation of Myopericardial Diseases -- 1: Essential Anatomy and Physiology of the Pericardium for Clinical Practice -- 1.1 Anatomy of the Pericardium -- 1.2 Physiology of the Pericardium -- References -- 2: Aetiology and Classification of Pericardial Diseases -- 2.1 Overview and Epidemiology -- 2.2 Infectious Aetiologies -- 2.3 Non-infectious Aetiologies -- 2.4 Pericardial Syndromes -- References -- 3: Diagnosis: History, Physical Examination and ECG -- 3.1 History -- 3.2 Physical Examination -- Pericardial Rubs -- Physical Signs in Large Pericardial Effusions/Cardiac Tamponade -- Physical Signs in Constrictive Pericarditis -- 3.3 Electrocardiogram -- References -- 4: Multimodality Imaging of Pericardial/Myopericardial Diseases -- 4.1 Introduction -- 4.2 Chest X-Ray -- 4.3 Echocardiography -- 4.4 Computed Tomography (CT) -- 4.5 Cardiac Magnetic Resonance (CMR) -- 4.6 Nuclear Medicine -- 4.7 Multimodality Imaging -- References -- 5: Cardiac Catheterization and Interventional Techniques -- 5.1 Cardiac Catheterization -- Cardiac Tamponade -- Constrictive Pericarditis -- 5.2 Pericardiocentesis -- 5.3 Pericardioscopy, Pericardial Biopsy and Intrapericardial Therapies -- References -- 6: Principles of Medical Therapy of Pericardial Diseases -- 6.1 Overview -- 6.2 Aspirin and Non-steroidal Anti-inflammatory Drugs (NSAID) -- Mechanism of Action -- Indications -- Main Contraindications, Warnings, Precautions and Interactions -- Adverse Events -- Special Populations -- Common Prescribed Drugs and Dosing -- 6.3 Colchicine -- Mechanism of Action -- Indications -- Main Contraindications, Warnings, Precautions and Interactions -- Adverse Events -- Special Populations -- Common Dosing -- 6.4 Corticosteroids -- Mechanism of Action -- Indications -- Adverse Events -- Special Populations. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Common Dosing -- 6.5 Azathioprine, Human Intravenous Immunoglobulin (IVIG) and Anakinra -- Azathioprine -- Intravenous Immunoglobulins (IVIG) -- Anakinra and Biological Agents -- References -- 7: Surgery for Pericardial Diseases -- 7.1 Introduction -- 7.2 Non-constrictive Pericardial Diseases -- Pericardial Window -- 7.3 Constrictive Pericardial Diseases -- References -- Part II: Myopericardial Syndromes -- 8: Pericardial Syndromes -- References -- 9: Acute Pericarditis: Management Overview -- 9.1 Definition -- 9.2 Presentation -- 9.3 Aetiology and Diagnosis -- 9.4 Diagnostic Work-Up and Management -- 9.5 Therapy -- 9.6 Outcome and Prognosis -- References -- 10: Acute Pericarditis: Specific Aetiologies (Non-viral, Non-idiopathic) -- 10.1 Bacterial Pericarditis -- Tuberculous Pericarditis -- Diagnosis -- Medical Therapy -- Prognosis -- Purulent Pericarditis -- Medical Therapy -- Prognosis -- 10.2 Pericarditis in Renal Failure -- 10.3 Pericardial Involvement in Systemic Autoimmune and Autoinflammatory Diseases -- Medical Therapy -- 10.4 Post-cardiac Injury Syndromes -- Definition and Diagnostic Criteria -- Medical Therapy -- Prognosis -- 10.5 Neoplastic Pericarditis -- Medical Therapy -- 10.6 Radiation Pericarditis -- References -- 11: Recurrent Pericarditis -- 11.1 Definition -- 11.2 Presentation -- 11.3 Aetiology and Diagnosis -- 11.4 Diagnostic Work-Up and Management -- 11.5 Therapy -- 11.6 Outcomes and Prognosis -- References -- 12: Pericarditis Associated with Myocardial Involvement (Myopericarditis/Perimyocarditis) -- 12.1 Definitions -- 12.2 Presentation -- 12.3 Aetiology and Diagnosis -- 12.4 Diagnostic Work-Up and Management -- 12.5 Therapy -- 12.6 Outcomes and Prognosis -- References -- 13: Pericardial Effusion -- 13.1 Definition -- 13.2 Presentation -- 13.3 Aetiology and Diagnosis. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 13.4 Diagnostic Work-Up and Management -- 13.5 Therapy -- 13.6 Outcomes and Prognosis -- References -- 14: Cardiac Tamponade -- 14.1 Definition -- 14.2 Presentation -- 14.3 Aetiology and Diagnosis -- 14.4 Diagnostic Work-Up and Management -- 14.5 Therapy -- 14.6 Outcomes and Prognosis -- References -- 15: Constrictive Pericarditis -- 15.1 Definition -- 15.2 Presentation -- 15.3 Aetiology and Diagnosis -- 15.4 Diagnostic Work-Up and Management -- 15.5 Therapy -- 15.6 Outcomes and Prognosis -- References -- 16: Congenital Abnormalities of the Pericardium and Pericardial Masses -- 16.1 Classification -- 16.2 Congenital Abnormalities of the Pericardium -- Pericardial Defects -- Congenital Cysts -- 16.3 Pericardial Masses -- Cysts -- Pericardial Tumours -- Secondary Tumours -- Pericardial Haematomas -- 16.4 Multimodality Imaging for Pericardial Masses and Cysts -- References -- Part III: Specific Populations, Guidelines, Conclusions and Perspectives -- 17: Age and Gender Issues in the Management of Pericardial Diseases -- 17.1 Introduction -- 17.2 Children -- 17.3 Pregnancy and Lactation -- 17.4 The Elderly -- References -- 18: Guidelines on the Management of Pericardial Diseases -- 18.1 Overview and Introduction -- 18.2 What's New in Pericardial Diseases? -- 18.3 How 2015 ESC Guidelines Are Structured and Main Messages -- References -- 19: Conclusions -- 20: Perspectives and Unmet Needs. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Heart_xSurgery. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Imazio, Massimo |
| Title | Myopericardial Diseases |
| Place, publisher, and date of publication | Cham : Springer International Publishing AG,c2016 |
| International Standard Book Number | 9783319271545 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=4415551">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=4415551</a> |
| Public note | Click to View |
No items available.